M Holdings Securities, Inc. Amgen Inc Transaction History

M Holdings Securities, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $1.18 Million - $1.44 Million	4,500 New	4,500 $1.41 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $54,415 - $66,323	241 Added 11.97%	2,255 $545,000
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $89,779 - $114,075	-392 Reduced 16.29%	2,014 $529,000
Q3 2022 Nov 16, 2022	SELL	$224.46 - $253.15 $39,729 - $44,807	-177 Reduced 6.85%	2,406 $542,000
Q2 2022 Aug 16, 2022	BUY	$230.71 - $256.74 $10,612 - $11,810	46 Added 1.81%	2,583 $628,000
Q1 2022 May 24, 2022	BUY	$219.27 - $242.57 $556,287 - $615,400	2,537 New	2,537 $613,000
Q2 2021 Aug 19, 2021	SELL	$233.58 - $259.14 $560,358 - $621,676	-2,399 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $532,362 - $620,381	2,399 New	2,399 $597,000
Q2 2019 Aug 16, 2019	SELL	$166.7 - $195.41 $446,422 - $523,307	-2,678 Closed	0 $0
Q1 2019 May 17, 2019	BUY	$180.87 - $203.88 $40,153 - $45,261	222 Added 9.04%	2,678 $509,000
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $63,688 - $74,345	-357 Reduced 12.69%	2,456 $478,000
Q3 2018 Nov 16, 2018	SELL	$185.29 - $208.89 $11,487 - $12,951	-62 Reduced 2.16%	2,813 $583,000
Q2 2018 Aug 17, 2018	BUY	$166.05 - $186.51 $42,176 - $47,373	254 Added 9.69%	2,875 $531,000
Q1 2018 May 18, 2018	SELL	$169.43 - $198.0 $80,648 - $94,248	-476 Reduced 15.37%	2,621 $447,000
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $8,608 - $9,618	51 Added 1.67%	3,097 $359,000
Q3 2017 Nov 15, 2017	SELL	$167.29 - $191.0 $501 - $573	-3 Reduced 0.1%	3,046 $568,000
Q2 2017 Aug 22, 2017	BUY	N/A	3,049	3,049 $525,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.